Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) [Yahoo! Finance]
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing [Yahoo! Finance]